N,N′-diisopropylcarbodiimide structure
|
Common Name | N,N′-diisopropylcarbodiimide | ||
|---|---|---|---|---|
| CAS Number | 693-13-0 | Molecular Weight | 126.200 | |
| Density | 0.8±0.1 g/cm3 | Boiling Point | 146.5±9.0 °C at 760 mmHg | |
| Molecular Formula | C7H14N2 | Melting Point | 210-2120C (dec) | |
| MSDS | Chinese USA | Flash Point | 33.9±0.0 °C | |
| Symbol |
GHS05, GHS06, GHS08 |
Signal Word | Danger | |
| Name | 1,3-diisopropylcarbodiimide |
|---|---|
| Synonym | More Synonyms |
| Density | 0.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 146.5±9.0 °C at 760 mmHg |
| Melting Point | 210-2120C (dec) |
| Molecular Formula | C7H14N2 |
| Molecular Weight | 126.200 |
| Flash Point | 33.9±0.0 °C |
| Exact Mass | 126.115700 |
| PSA | 24.72000 |
| LogP | 3.18 |
| Vapour Pressure | 5.8±0.3 mmHg at 25°C |
| Index of Refraction | 1.445 |
| InChIKey | BDNKZNFMNDZQMI-UHFFFAOYSA-N |
| SMILES | CC(C)N=C=NC(C)C |
| Storage condition | 2-8°C |
| Symbol |
GHS05, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H315-H317-H318-H330-H334-H335 |
| Precautionary Statements | P260-P280-P284-P305 + P351 + P338-P310 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | T+:Verytoxic; |
| Risk Phrases | R10;R26;R36/37/38;R41;R42/43 |
| Safety Phrases | S26-S36/37/39-S45-S38-S28A-S16 |
| RIDADR | UN 2929 6.1/PG 1 |
| WGK Germany | 3 |
| RTECS | FF2175000 |
| Packaging Group | II |
| Hazard Class | 6.1 |
| HS Code | 29252000 |
| Precursor 10 | |
|---|---|
| DownStream 10 | |
| HS Code | 2921199090 |
|---|---|
| Summary | 2921199090 other acyclic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
|
LRRK1-phosphorylated CLIP-170 regulates EGFR trafficking by recruiting p150Glued to microtubule plus ends.
J. Cell Sci. 128(2) , 385-96, (2015) The binding of ligand to epidermal growth factor receptor (EGFR) causes the receptor to become activated and stimulates the endocytosis of EGFR. Early endosomes containing activated EGFR migrate along... |
|
|
DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity.
J. Exp. Med. 211(13) , 2549-66, (2014) DOCK8 mutations result in an inherited combined immunodeficiency characterized by increased susceptibility to skin and other infections. We show that when DOCK8-deficient T and NK cells migrate throug... |
|
|
Incorporation of electrochemical advanced oxidation processes in a multistage treatment system for sanitary landfill leachate.
Water Res. 81 , 375-87, (2015) The current study has proved the technical feasibility of including electrochemical advanced oxidation processes (EAOPs) in a multistage strategy for the remediation of a sanitary landfill leachate th... |
| 2-Propanamine, N,N'-methanetetraylbis- |
| DIC/DIPCDI |
| diisopropylcarbodiimide |
| 2-Propanamine, N-[(1-methylethyl)carbonimidoyl]- |
| N,N'-dipropan-2-ylcarbodiimide |
| N,N'-bis(1-methylethyl)carbodiimide |
| DICI |
| 1,3-Diisopropyl carbodiimide |
| N,N'-diisopropylcarb |
| DIPCDI |
| DIPCI |
| 1,3-di-iso-propylcarbodiimide |
| PCI |
| 1,3-diisopropylcarbodiimide |
| DIPC |
| N,N'-di-iso-propylcarbodiimide |
| diisopropyl-carbodiimid |
| MFCD00065689 |
| N,N'-Diisopropylcarbodiimide |
| EINECS 211-743-7 |
| Carbodiimide, diisopropyl- |
| N,N'-Dipropan-2-ylcarbodiimid |
| DIC |
| Bosutinib Impurity 11 |